Skip to content

Posts by Jeremy Schmahmann, MD


Jeremy D. Schmahmann, M.D. is Founding Director of the MGH Ataxia Unit, a member of the Cognitive Behavioral Neurology Unit, and Professor of Neurology at Harvard Medical School (HMS). He graduated with distinction from the University of Cape Town, winning the Nestle Prize (pediatrics) and Wilfrid Exner Bauman Prize (best student). After residency in the Boston City Hospital Neurological Unit, and fellowship in the Boston University School of Medicine Department of Anatomy and Neurobiology, he joined the MGH faculty in 1989. He has been cited in The Best Doctors in America since 1996, is a Fellow of the American Academy of Neurology, the American Neurological Association, and the American Neuropsychiatric Association, member of the National Ataxia Foundation medical research advisory board, the Cerebellar Research Consortium, and the Multiple System Atrophy Global Working Group.

Dr. Schmahmann won the 2000 Norman Geschwind Prize from the American Academy of Neurology and Behavioral Neurology Society for pioneering research on the cerebellum and cognition, the 2008 Distinguished Neurology Teacher Award from the American Neurological Association, and the 2013 Special Award for Sustained Excellence in Teaching in from HMS. His neurological and neuroanatomical research has been funded by NIH and private foundations. Dr. Schmahmann was a Founding Co-Director of the HMS Dementia Course, and has over 180 publications in peer-reviewed journals and academic texts. He has authored and edited 5 books: The Cerebellum and Cognition (Academic Press), MRI Atlas of the Human Cerebellum (Academic Press), Fiber Pathways of the Brain (Oxford University Press), Cerebellar Disorders in Children (Mac Keith Press), and Handbook of the Cerebellum and Cerebellar Disorders (Springer).

Neuroscience Care at Mass General

Through a combination of unmatched expertise, creativity and compassion, Mass General Neuroscience relentlessly advances the fields of Neurosurgery, Neurology and Psychiatry to unleash our patients’ potential.